(Rickels et al. Fluoxetine 20-80 q.d. No 6+48 T6 94 60 37 No 14 - No 1985)() Fluoxetine 20-80 b.i.d. 94 60 37 9 - (Rickels et al. Paroxetine 31.5 ± 1.25 Yes 6 T6 55 69.2 43.4 No 9 13 No 1992)() Placebo 56 59.1 46.0 5 4 (Roose et al. Citalopram 10-40 No 8 T8 84 53.6 79.8 ± 4.0 No 3 5 Yes 2004)() Placebo 90 62.2 79.3 ± 4.7 5 4 (Rosso et al. Bupropion 300 Yes 6 T6 21 71.4 46.6 No 1 - No 2012)() Duloxetine 120 25 64 47.6 0 - (Rudolph et al. Venlafaxine 75 No 6 T6 89 40 43.6 No 20 15 Yes 1998)() Venlafaxine 225 89 43 43.1 18 16 Venlafaxine 375 88 33 43.8 12 23 Placebo 92 32 41.5 9 4 (Rudolph et al. Fluoxetine 47 Yes 8 T8 103 73 40 No - 12 Yes 1999)() Venlafaxine XR 175 100 69 40 - 8 Placebo 98 64 40 - 6 (Russell et al. Sertraline 141.0±59.4 No 6 T6 155 65.1 41.6± 10.6 SUD, anxiety 43 - Yes 2001)() disorders, personality disorders (Sacchetti et al. Paroxetine 20-50 Yes 12 T12 64 64.1 48.7 No 3 3 No 2002)() (Samuelian et Venlafaxine 105 Yes 6 T6 52 73.1 47 ± 12 No - 3 Yes al. 1998)()
(Rickels et al. 1985)() Fluoxetine Fluoxetine 20-80 q.d. 20-80 b.i.d. No 6+48 T6 94 94 60 60 37 37 No 14 9 - - No (Rickels et al. 1992)() Paroxetine Placebo 31.5 ± 1.25 Yes 6 T6 55 56 69.2 59.1 43.4 46.0 No 9 5 13 4 No (Roose et al. 2004)() Citalopram Placebo 10-40 No 8 T8 84 90 53.6 62.2 79.8 ± 4.0 79.3 ± 4.7 No 3 5 5 4 Yes (Rosso et al. 2012)() Bupropion Duloxetine 300 120 Yes 6 T6 21 25 71.4 64 46.6 47.6 No 1 0 - - No (Rudolph et al. 1998)() Venlafaxine Venlafaxine Venlafaxine Placebo 75 225 375 No 6 T6 89 89 88 92 40 43 33 32 43.6 43.1 43.8 41.5 No 20 18 12 9 15 16 23 4 Yes (Rudolph et al. 1999)() Fluoxetine Venlafaxine XR Placebo 47 175 Yes 8 T8 103 100 98 73 69 64 40 40 40 No - - - 12 8 6 Yes (Russell et al. 2001)() Sertraline 141.0±59.4 No 6 T6 155 65.1 41.6± 10.6 SUD, anxiety disorders, personality disorders 43 - Yes (Sacchetti et al. 2002)() Paroxetine 20-50 Yes 12 T12 64 64.1 48.7 No 3 3 No (Samuelian et al. 1998)() Venlafaxine 105 Yes 6 T6 52 73.1 47 ± 12 No - 3 Yes
JCP_00_00_2015_03_31_SERRETTI_JCP14173_SDC1.docx